The DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Open accessAbstract
Fungal infections are a major contributor to infectious disease-related deaths across the globe. Candida species are among the most common causes of invasive mycotic disease, with Candida albicans reigning as the leading cause of invasive candidiasis. Given that fungi are eukaryotes like their human host, the number of unique molecular targets that can be exploited for antifungal development remains limited. Currently, there are only three major classes of drugs approved for the treatment of invasive mycoses, and the efficacy of these agents is compromised by the development of drug resistance in pathogen populations. Notably, the emergence of additional drug-resistant species, such as Candida auris and Candida glabrata, further threatens the limited armamentarium of antifungals available to treat these serious infections. Here, we describe our current arsenal of antifungals and elaborate on the resistance mechanisms Candida species possess that render them recalcitrant to therapeutic intervention. Finally, we highlight some of the most promising therapeutic strategies that may help combat antifungal resistance, including combination therapy, targeting fungal-virulence traits, and modulating host immunity. Overall, a thorough understanding of the mechanistic principles governing antifungal drug resistance is fundamental for the development of novel therapeutics to combat current and emerging fungal threats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, large-scale genomic alterations, including aneuploidy, loss-of-heterozygosity (LOH), and chromosomal rearrangements, can affect the expression of drug targets, efflux pumps, and other resistance factors (7).”
From Potential role of lysine acetylation in the stepwise adaptation of Candida albicans to fluconazole (2025) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“These mutations lead to either the overexpression of the enzyme itself (14) or alterations in its activity that can lower fluconazole’s binding strength, leading to reduced drug effectiveness (15).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [15]
In the citing paper
“the only new class of antifungal drugs developed in decades, the echinocandins, displays negligible antifungal activity against Cryptococcus spp.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“Treatment options for invasive cryptococcal infection are limited, given that Cryptococcus spp. are intrinsically resistant to echinocandins and that they employ an arsenal of defences that enable resistance to azoles2,8.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“the polyene amphotericin B has been the primary treatment for cryptococcal infection for more than half a century, despite the fact that it causes substantial toxicity and that its availability is limited by economic and logistical constraints2,4”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“current antifungal drug treatments for invasive fungal infections are limited to polyenes, azoles and echinocandins2”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“Combination therapy has the potential to confer enhanced efficacy and fungal selectivity while reducing vulnerability to the evolution of resistance2.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,455
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
The Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
Fisher, M. C., Hawkins, N. J., Sanglard, D., & Gurr, S. J. (2018) · Science · doi:10.1126/science.aap7999 · Cited by 1,555
Flagged first, then by citations
Research works printed but not linked: 1
- Besterman, J.; Nguyen, D. T.; Ste-Croix, H. MGCD290, an Oral Fungal Hos2 Inhibitor, Enhances the Antifungal Properties of Fluconazole Following Multiple-or Single-Dose Oral Administration in Pre-and Post-Infection Settings. In Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) ; MethylGene, Inc.: San Francisco, CA, 2012; Vol. Poster M-1711.
Cited by
Sorted by citations
Items 501–600 of 823
Minimal domain peptides derived from enterocins exhibit potent antifungal activity
Cohen, D. G., Heidenreich, T. M., Schorey, J. W., Ross, J. N., Hammers, D. E., Vu, H. M., Moran, T. E., Winski, C. J., Stuckey, P. V., Ross, R. L., et al. (2024) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2024.1506315 · Cited by 3
Functional analysis of Candida albicans Cdr1 through homologous and heterologous expression studies
Zhao, M., Lamping, E., Niimi, K., Niimi, M., & Cannon, R. D. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf012 · Cited by 3
Cairone, F., Angiolella, L., Bertini, F., Iazzetti, A., Fabrizi, G., Petralito, S., Cesa, S., & Simonetti, G. (2025) · Foods · doi:10.3390/foods14081332 · Cited by 3
Wei, Y., Zhao, X., Li, C., Fu, J., Gao, W., & Mao, X. (2025) · Microbial Cell Factories · doi:10.1186/s12934-025-02721-0 · Cited by 3
Relevante Aspekte zu Candida-Spezies in der Dermatologie
Müller, V. L., Kreuter, A., Uhrlaß, S., & Nenoff, P. (2025) · Die Dermatologie · doi:10.1007/s00105-025-05538-5 · Cited by 3
Sánchez-Villacreses, E. M., Tapia, J. C., Cáceres-Valdiviezo, M. J., Gabriel Morey-León, G., Fernández‐Cadena, J. C., & Andrade-Molina, D. (2025) · All Life · doi:10.1080/26895293.2025.2551757 · Cited by 3
Voropaev, A. D., Yekaterinchev, D. A., Urban, Y. N., Zverev, V. V., Nesvizhsky, Y. V., Voropaev, A. D., Likhanskaya, E. I., Afanasiev, M. S., & Afanasiev, S. S. (2022) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-ccm-1931 · Cited by 3
Lu, J., Xu, Z.-C., Zhu, H., Zhu, L.-Y., Ma, X.-R., Wang, R., Li, R., & Ye, R. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1200747 · Cited by 3
Arı, E., Şahin, N., Üstün, E., Dündar, M., Karcı, H., Özdemir, İ., Koç, A., Gürbüz, N., & Özdemir, İ. (2023) · Polyhedron · doi:10.1016/j.poly.2023.116758 · Cited by 3
Teixeira, B. D. A., Souza, H. D. D. S., Fiss, G. F., Filho, P. F. D. A., Nogueira, P. L., Alves, D. D. N., de Castro, R. D., Júnior, F. P. D. A., Farias, B. K. D. S., & Lima, E. D. O. (2023) · OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA · doi:10.55905/oelv21n12-035 · Cited by 4
Carbon Nanomaterials in Drug and Gene Delivery Potential: Focus on Fungal Infections
Kumar, P., Singh, R., Kaur, G., & Chawla, S. (2024) · Smart nanomaterials technology · doi:10.1007/978-981-97-0240-4_12 · Cited by 3
Isolation and Identification of Antifungal Metabolites from Juncus torreyi
Park, S. H., Kang, J. W., Park, G. H., Jo, S.-J., Min, K.-W., Lee, K. S., & Park, H. B. (2024) · Natural Product Sciences · doi:10.20307/nps.2024.30.2.161 · Cited by 3
Unveiling the roles of CaSDH8 in Candida albicans : Implications for virulence and azole resistance
Huang, M., Song, D., Zhou, L., Jiao, Z., Yang, L., Yang, Y., Peng, J., & Guo, G. (2024) · Virulence · doi:10.1080/21505594.2024.2405000 · Cited by 3
Inhibition of Candida albicans virulence by moscatin from Dendrobium nobile lindl.
Wang, B., Tan, H., Sun, X., Lin, Z., Chen, X., Han, H., Wang, M., Wang, Z., Chen, X., Deng, Y., et al. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107089 · Cited by 3
A cell wall-targeting urease-derived peptide as a potential antifungal agent against Candida species
Perin, A. P. A., Reuwsaat, J. C. V., Motta, H., Lopes, F. C., Grahl, M. V. C., Tavanti, A. G., Vainstein, M. H., Staats, C. C., Carlini, C. R., Ligabue‐Braun, R., et al. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100399 · Cited by 3
Usmani, S. A., Arya, K., Ali, B., Chandra, S., Chaturvedi, S., Srivastava, D., Khanna, K., Bhardwaj, N., Prasad, R., & Singh, A. (2025) · Lipids · doi:10.1002/lipd.12455 · Cited by 3
Wu, J., Jiang, Z., Yan, R., Sun, S.-H., Yu, Y. Q., & Shen, L. R. (2021) · Organic Chemistry Frontiers · doi:10.1039/d1qo01038g · Cited by 3
Gu, Y., Zhang, L., Liu, J., Zhang, X., Liu, N., & Liu, Q. (2022) · Photochemistry and Photobiology · doi:10.1111/php.13637 · Cited by 3
Huang, M., Yang, L., Zhou, L., Sun, C., Zhao, W., Peng, J., Jiao, Z., Tian, C., & Guo, G. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.990318 · Cited by 3
Shi, W., Zhao, R., Zhu, J.-Q., Wan, X., Wang, L., Li, H., & Qin, S. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02865-2 · Cited by 3
Isolation and Antifungal Susceptibility of Candida spp. from Pediatric Patients
Bahi, M. S., & Shekhany, K. A. M. (2023) · Kurdistan Journal of Applied Research · doi:10.24017/science.2023.1.5 · Cited by 3
The Emergence of N. sativa L. as a Green Antifungal Agent
Pandey, R., Pandey, B., & Bhargava, A. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575282914240217060251 · Cited by 5
Genetic landscape of an in vivo protein interactome
Besse, S., Sakaguchi, T., Gauthier, L., Sahaf, Z., Ravindran, R., González, L., Castellanos-Girouard, X., Clermont, C., Kocatuğ, N., Péloquin, O., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02747-z · Cited by 3
Discovery and development of novel substituted monohydrazides as potent antifungal agents
Chandrika, N. T., Green, K. D., Spencer, A. C., Tsodikov, O. V., & Garneau‐Tsodikova, S. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00167a · Cited by 2
Rezaei, R., Aliannejad, R., Falahati, M., Ghasemi, Z., Ashrafi‐Khozani, M., Fattahi, A., Razavi, T. D. A., & Farahyar, S. (2024) · Iranian Journal of Microbiology · doi:10.18502/ijm.v16i2.15362 · Cited by 2
Wang, Y., Zhang, Y., Leng, H., & Dong, J. (2024) · Medical Mycology · doi:10.1093/mmy/myae050 · Cited by 2
Mangiferin potentiates the activity of antifungal agents against fluconazole-resistant Candida spp.
Ferreira, T. L., Leitão, A. C., da Silva, L. J., Sá, L. G. D. A. V., Cabral, V. P. D. F., Rodrigues, D. S., Barbosa, S. A., Neto, J. B. D. A., Barbosa, A. D., Moreira, L. E. A., et al. (2024) · Future Microbiology · doi:10.1080/17460913.2024.2366627 · Cited by 4
Fattouh, N., Hdayed, D., Hijazi, A., Tokajian, S. T., & Khalaf, R. A. (2024) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2024.07.010 · Cited by 2
MECANISMOS DE RESISTÊNCIA ANTIFÚNGICA: EXPLORAÇÃO DOS ASPECTOS MOLECULARES E GENÉTICOS
Araújo, T. C., de Araújo, G. D. F. L., Santos, K. D. S., Veloso, T. R. M., Costa, L. R., Dourado, J. D. S., Filho, J. C. D. S., Mendonça, W. V. L., Costa, N. C. A., Santos, V. A. P., et al. (2024) · Revista Foco · doi:10.54751/revistafoco.v17n9-006 · Cited by 2
Golden Guardians: Advanced pH Sensors with Built‐in Antimicrobial Defense
Justo‐Tirado, M., Pérez‐Herráez, I., Dea‐Ayuela, M. A., Galiana, C., González‐García, J., Zaballos-Garcı́a, E., & Pérez‐Prieto, J. (2024) · Advanced Optical Materials · doi:10.1002/adom.202400472 · Cited by 2
Brittin, N. J., Aceti, D. J., Braun, D. R., Anderson, J. M., Ericksen, S. S., Rajski, S. R., Currie, C. R., Andes, D. R., & Bugni, T. S. (2024) · Molecules · doi:10.3390/molecules30010077 · Cited by 2
Qin, Y., Lv, Q., Xu, H., Cao, Y., & Han, B. (2025) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2024.2432424 · Cited by 2
Wu, M.-F., Yang, J., Chen, Y., Zeng, Z., Deng, W., Su, X. D., & Xue, Y. (2025) · Phytochemical Analysis · doi:10.1002/pca.70024 · Cited by 2
Allyl isothiocyanate suppresses the growth and pathogenicity of Candida albicans
Nishiura, H., Tamura, M., Matsuike, R., Cueno, M. E., Ito, T., Namura, Y., Iinuma, T., & Imai, K. (2025) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2025.100125 · Cited by 2
Exploration of piperazine-azole hybrids as antifungal agents against drug-resistant Candida albicans
Xu, Z., Zhang, X. L., Wei, Y., Li, A., Mao, Z., & Wang, R. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.109181 · Cited by 2
Omics and Multiomics-Based Diagnostics for Invasive Candidiasis: Toward Precision Medicine
Pitarch, A., Arribas, V., & Gil, C. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101463 · Cited by 2
Yuan, X., Han, Y., Jin, Y., Cao, D., Dong, X., Xiang, Y., Bi, K., & Zhang, Y. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157695 · Cited by 2
Kenaan, H., Duncan, R., Al-Jamal, W. T., Jones, D. S., Andrews, G. P., Gilmore, B., Yardley, V., Farrington, N., Stott, K. E., Lawrence, D. S., et al. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100478 · Cited by 2
Pinheiro, A. B., Saha, S., Madduri, M., Roy, U., Menon, L. S., Biswas, S., Chatterjee, A., & Banerjee, M. (2026) · RSC Medicinal Chemistry · doi:10.1039/d5md00907c · Cited by 2
Gut fungal landscape in colorectal cancer and its cross-kingdom interplay with gut microbial ecology
Wu, Y., Jia, X., Zheng, W., Xiaojian, Y., Shu, X., Qingjie, Z., Lu, Y., & Han, S. (2026) · iScience · doi:10.1016/j.isci.2026.114664 · Cited by 2
Antifungal Activity of Four Medium-Chain Fatty Acids and γ-Undecalactone Against Candida albicans
Yoshida, M., Terada, H., Hayashi, S., Haraguchi, T., Watanabe, M., Yamashita, M., Yoshii, M., Hatanaka, Y., & Nagao, T. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48020150 · Cited by 2
Chen, F., Ye, Y., Yao, Y., He, J., Yu, X., Zhang, R., Ailifeire, H., Luo, C., Yao, K., Tang, X., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04088-9 · Cited by 2
Mies, K., Hermes, G., Beckers, J., Mörgelin, M., Simon, M., Ruegamer, T., Jantsch, J., Klatt, A. R., Streichert, T., & Elezagic, D. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1756518 · Cited by 2
Inhibiting Mrt4-rRNA interaction with fumaramidmycin-based derivatives as an antifungal strategy
Cao, H., Tu, J., Chen, J., Chen, B., Huang, Z., Wang, Y., Shen, J., Hu, X., Bo, J., Rao, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70226-4 · Cited by 3
Shao, T., Zhang, Y., Xue, B., & Chu, W. (2026) · Microbial Biotechnology · doi:10.1111/1751-7915.70331 · Cited by 2
Castillo, Y. L., Márquez, E., Peralta-Ruiz, Y. Y., Chaves‐López, C., Saurith-Coronell, O., & Grande‐Tovar, C. D. (2026) · Molecules · doi:10.3390/molecules31071132 · Cited by 2
Zu, W.-B., Wang, Z.-J., Tang, D.-M., Lu, Q.-Y., Zhu, Y.-Y., Zhou, Z.-S., Wei, M.-Z., & Luo, X.-D. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158142 · Cited by 2
Gador‐Whyte, A., Rhodes, J., Farrer, R. A., Bakker, S., Wirth, W., Coldbeck-Shackley, R. C., Howden, B. P., Kwong, J. C., Sherry, N. L., & Seemann, T. (2026) · Microbial Genomics · doi:10.1099/mgen.0.001710 · Cited by 2
Agricultural fungicides shape soil and sediment reservoirs of multidrug-resistant fungi
Zhao, Q., Wang, Q., Wang, Q., Wang, Q., Li, Y., Ma, H., Gao, J., & Li, X. (2026) · Nature Communications · doi:10.1038/s41467-026-73958-5 · Cited by 3
Li, Q., Pang, Y., Zhang, J., Liu, Y., Chen, H., Wang, Y., Mei, L., Tu, L., Li, J., & Sun, Y. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c10086 · Cited by 2
Wu, J., Li, R., Shen, Y., Zhang, X., Wang, X., Wang, Z., Zhao, Y., Zhang, L., Zhang, L., & Zhang, B. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.01.083 · Cited by 2
Liu, Y., Ren, F., Li, S., Li, X., Shi, D., & Zhang, Z. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s459378 · Cited by 3
Jaquelin, N.-B., Romero-Romero, D., Contreras-Rodríguez, A., Aguilera‐Arreola, M. G., & Parra-Ortega, B. (2024) · Archives of Medical Research · doi:10.1016/j.arcmed.2024.103038 · Cited by 2
Río, M. D., Radicioni, M. B., Cutine, A. M., Mariño, K. V., Mora-Montes, H. M., Cagnoni, A. J., & Regente, M. C. (2024) · Glycobiology · doi:10.1093/glycob/cwae058 · Cited by 2
Mohanraj, H., Vinodhini, V. M., & Vajravelu, L. K. (2024) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.18.3.45 · Cited by 2
Antifungal Resistance in Candida albicans
Seyedjavadi, S. S., Hatami, F., & Jahanshiri, Z. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004578 · Cited by 3
Identification of ABC transporter Cdr1 inhibitors of Candida glabrata
Waseem, M., Das, S., Mondal, D., Kumari, A., Kulshreshtha, R., Thakur, J. K., & Subbarao, N. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110270 · Cited by 2
Molecular Epidemiology and Antifungal Susceptibility Profile of Candidozyma Isolates From Argentina
Taverna, C. G., Córdoba, S. B., Haim, M. S., Lombardo, M., Vivot, M. E., Arias, B. A., Vivot, W., Szusz, W., Abbey, D., Poklépovich, T., et al. (2025) · Mycoses · doi:10.1111/myc.70025 · Cited by 2
RELAÇÃO ENTRE O COMPORTAMENTO ALIMENTAR E O ESTADO NUTRICIONAL DE UNIVERSITÁRIOS
Rosa, L. A. S., de Sousa, L. M., da Silva, M. C. N., da Cruz, T. M., Dumaresq, L. D. F. M. D. L., Vasconcelos, A. S., Câmara, J. N. R., & Sobreira, I. E. M. M. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c17 · Cited by 2
Doss, E. M., Moore, J. M., Harman, B. H., Doud, E. H., Rubenstein, E. M., & Bernstein, D. A. (2023) · PeerJ · doi:10.7717/peerj.15897 · Cited by 2
da Silva, L. J., Rodrigues, D. S., Cabral, V. P. D. F., da Silva, C. R., Sá, L. G. D. A. V., Neto, J. B. D. A., Barbosa, A. D., Flaresso, A. A., da Rocha, S. N. C., Cavalcanti, B. C., et al. (2024) · Brazilian Journal of Microbiology · doi:10.1007/s42770-024-01498-5 · Cited by 2
Coutinho, T. D. N. P., Rodrigues, F. A. M., de Assis, D. A., Rebouças, L. M., Ferreira, T. L., Cabral, V. P. D. F., Rodrigues, D. S., Sá, L. G. D. A. V., Lopes, F. F. D. S., do Nascimento, G. A., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.139788 · Cited by 2
Abrantes, P. M. D. S., Fisher, R., Bouic, P. J., McArthur, C. P., Fielding, B. C., Africa, C. W. J., & Synexa Life Sciences, P. B. 3. (2021) · AIMS Microbiology · doi:10.3934/microbiol.2021020 · Cited by 4
Korol, N. I., Головко-Камошенкова, О. М., Slivka, M. V., Tymoshchyk, S., & Boyko, N. (2022) · Scientific Bulletin of the Uzhhorod University Series «Chemistry» · doi:10.24144/2414-0260.2021.2.49-54 · Cited by 3
Metsopkeng, C. S., Nougang, M. E., Arfao, A. T., Pérrière, F., Moungang, L. M., Ewoti, O. V. N., Donnadieu, F., Nana, P. A., Bricheux, G., Eheth, J. S., et al. (2022) · Bacterial Empire · doi:10.36547/be.484 · Cited by 3
Bollin, P., Pierański, M. K., Szcześniak, M. W., & Szweda, P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.23.720452 · Cited by 2
Ali, H., Khaliq, S., Ali, B., Mushtaq, N., & Abbasi, S. A. (2024) · Journal of Liaquat University of Medical & Health Sciences · doi:10.22442/jlumhs.2024.01049 · Cited by 1
Vidarabine as a novel antifungal agent against Candida albicans: insights on mechanism of action
Gavandi, T. C., Basrani, S. T., Chougule, S. A., Patil, S. B., Nille, O. S., Kolekar, G. B., Yankanchi, S. R., Karuppayil, S. M., & Jadhav, A. K. (2024) · International Microbiology · doi:10.1007/s10123-024-00565-z · Cited by 1
You, Z., Dai, Y., & Ran, Y. (2024) · Future Microbiology · doi:10.1080/17460913.2024.2408136 · Cited by 1
Wang, X., Wang, Y., Zhang, H., Zhao, Y., Zeng, J., Gao, R., Chen, Z., Lv, K., Ma, D., & Fan, J. (2025) · Materials Today Communications · doi:10.1016/j.mtcomm.2025.112316 · Cited by 1
Yan, S., Kowah, J. A. H., Long, Q., Liu, Q., Zhang, H., Lu, S., Wang, L., & Yu, H. (2025) · RSC Advances · doi:10.1039/d5ra01689d · Cited by 1
Cruz-Martínez, Y. R., Hernández, T., Méndez-Cuesta, C. A., & Delgado, G. (2025) · Journal of Applied Microbiology · doi:10.1093/jambio/lxaf160 · Cited by 1
Tambur, Z., Avramov, S., Aleksić, E., Joksić, A., Dimitrijevic, U., & Biočanin, V. (2025) · Stomatoloski glasnik Srbije · doi:10.2298/sgs2501003t · Cited by 1
Filippatos, F., Karava, V., Kakleas, K., Santou, A., & Michos, A. G. (2025) · Cureus · doi:10.7759/cureus.87740 · Cited by 1
Jiang, L., Yang, L., Yang, L., Yang, B., Xing, L., Liu, J., Yan, R., Han, J., Li, G., & Wang, R. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117181 · Cited by 1
Yao, S., Han, Q., Huang, X., Lu, J., Pi, W., Wang, Z., Zhao, Y., Guo, F., Tan, X., Zhang, L., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123598 · Cited by 1
Anti-candida Efficacy of Myrceugenia exsucca Essential Oil: An In Vitro and In Silico Evaluation
Madrid, A., Silva, V., Fuentes, B., Muñoz, E., Venegas, C., & Montenegro, I. (2025) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2025.101052 · Cited by 1
Li, J., Wang, Z., Zheng, R., Wang, Y., Guo, X., Li, X., & Zhang, P. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1641542 · Cited by 1
Benmessaoud, A., Yezli, W., Bensaid, M. O., & Mansouri, D. E. K. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108039 · Cited by 1
Cong, L., Zhang, Y., Chen, H., Lu, R., & Zhang, S. (2025) · Journal of Fungi · doi:10.3390/jof11100695 · Cited by 1
Resistance of ERG24 sterol C-14 reductase to heterocyclic amine antifungals
Arnold, C. J., Chartrain, L., Lawson, D. M., & Brown, J. K. M. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00155-7 · Cited by 1
Souza, T. D. F., Branca, M. T., Comitre, M. R. C., de Oliveira, D. A., Campos, L. M., Lemos, A. S. D. O., Paula, P. D. L., Ferreira, T. G., Gamarano, L. R., Diniz, I. O. M., et al. (2025) · ACS Omega · doi:10.1021/acsomega.5c05713 · Cited by 1
Xu, Y., Hu, S., Wu, Y., Chen, J., Fu, Z., Ma, T., Yuan, K., Zheng, L., Gu, F., & Yang, Y. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c05588 · Cited by 1
Silva, R. R. D. S., Carvalho, R. J. P., Santos, M. H. C., Santos, A. L. E., Carneiro, R. F., Nagano, C. S., Souza, P. F. N., & Teixeira, C. S. (2025) · Antibiotics · doi:10.3390/antibiotics14121228 · Cited by 1
Damti, C., Bazylevich, A., Sanyal, A., Semenova, O. M., Prakash, A., Hovor, I., Lubin, B. C. R., Patsenker, L. D., & Gellerman, G. (2025) · Molecules · doi:10.3390/molecules30234652 · Cited by 1
Exploring New Antifungal Agents for the Treatment of Candida Infections in the Era of Resistance
Bhatol, J., Dwivedi, S., Jain, V. K., Sisodiya, N., & Darwhekar, G. N. (2025) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3448 · Cited by 1
Wei, Y., & Mao, X. (2026) · BMC Microbiology · doi:10.1186/s12866-026-04767-5 · Cited by 1
Studi In Vitro : Aktivitas Antijamur Kulit Buah dan Daun Coffea canephora Terhadap Candida albicans
Widianingsih, M., & Aini, Y. A. (2026) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v9i2.1456 · Cited by 1
Antifungal effects of dibenzofuran derivatives against multi-azole resistant Candida albicans
Faleye, O. O., Mukhles, M. B., Boya, B. R., Kim, Y., Lee, J., & Lee, J. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109971 · Cited by 1
Jayasekara, L. A. C. B., Watchaputi, K., Euanorasetr, J., Poomputsa, K., Butkinaree, C., & Soontorngun, N. (2026) · FEMS Yeast Research · doi:10.1093/femsyr/foag021 · Cited by 1
Castelló-Abiétar, C., Alaguero, M., García-Carús, E., García-Prieto, E., Bolaños, S., Fernández-Suárez, J., & Garcia, T. P. (2026) · Journal of Fungi · doi:10.3390/jof12060428 · Cited by 1
Deptuła, P., Chmielewska-Deptuła, S. J., Spałek, J., Kaliniak, S., Okła, S., & Bucki, R. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119705 · Cited by 1
Neuro-Infections Caused By Candida Species
Fatima, N., & Ahmed, S. (2023) · Springer eBooks · doi:10.1007/978-981-99-6445-1_12 · Cited by 1
Exploring immunotherapy to control human infectious diseases
Rai, P., Mehrotra, S., & Prajapati, V. K. (2024) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2024.10.010 · Cited by 1
Nakiwala, R., Dasgupta, N., Wilson, R., Lutter, E. I., & Bolliger, J. L. (2025) · Pharmaceuticals · doi:10.3390/ph18020249 · Cited by 1
Cowen, A., Yiu, B., Fallah, S., Meyer, K. J., Puumala, E., Lee, Y., Zubyk, H. L., Robbins, N., Nodwell, J. R., MacAlpine, J., et al. (2025) · mSphere · doi:10.1128/msphere.00098-25 · Cited by 1
Self-citationNouraei, H., Ghahartars, M., Zareshahrabadi, Z., & Pakshir, K. (2025) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2025.100870 · Cited by 1
Introductory Chapter: Antimicrobial Resistance – Historical Perspectives and Future Directions
Mustafa, G., & Arif, R. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1010682 · Cited by 1
Sharma, S., Sharma, V., Dhar, M. K., & Kaul, S. (2025) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683824607005 · Cited by 1
Kouassi, F. K., David, K., Yapi, G. Y., Kouakou, J. K., Ama, V. B. I., Yakoura, K. O., Marina, D. B., Laura, A., Allico, J. D., & Ana, A.-I. (2025) · African Journal of Microbiology Research · doi:10.5897/ajmr2025.9798 · Cited by 1
Metadata
- Authors
- Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Cowen, Leah E.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-05-22
- Volume
- 121
- Issue
- 6
- Pages
- 3390-3411
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- PMC
- PMC8519031
- OpenAlex
- W3026958586
- Cited by
- 801
- References
- 237
- Citations by year
- 2026: 109 · 2025: 192 · 2024: 168 · 2023: 133 · 2022: 132 · 2021: 63 · 2020: 4
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Canadian Institutes of Health Research (FDN-154288)
- National Institute of Allergy and Infectious Diseases (1R01AI127375-01)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- antifungal resistance, Candida albicans, Candida auris, Candida glabrata, invasive candidiasis, antifungal agents, molecular mechanisms of resistance, combination antifungal therapy, fungal virulence factors, emerging fungal pathogens
- MeSH terms
- Drug Development, Animals, Antifungal Agents, Candida, Candida albicans, Drug Therapy, Combination, Humans, Mycoses, Virulence, Molecular Structure, Signal Transduction, Drug Resistance, Fungal, Candida glabrata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
